Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 4:05 PM View:  | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 16-Sep-24 | Grant | 3,282 | -- | -- | < 1% 16.54M to 16.54M | |
| 14-Aug-24 5:08 PM View: | Silver Ronald Principal Accounting Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Aug-24 | Sale | 3,107 | $4.27 | $13,266.90 | (2%) 161.48K to 158.37K | |
| 14-Aug-24 5:10 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Aug-24 | Sale | 9,910 | $4.27 | $42,315.70 | (3%) 294.57K to 284.66K | |
| 21-Jun-24 4:05 PM View: | Duane Jon R Director | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | 20% 121.03K to 145.34K | |
| 21-Jun-24 4:05 PM View: | Kessler Marla L Director | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | 25% 96.57K to 120.88K | |
| 21-Jun-24 4:05 PM View: | Dreyfus Andrew Director | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | 15% 163.92K to 188.23K | |
| 21-Jun-24 4:05 PM View: | Currie Mark G Director | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | 4% 544.11K to 568.42K | |
| 21-Jun-24 4:05 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | < 1% 16.51M to 16.54M | |
| 21-Jun-24 4:05 PM View: | Shepard Jay Director | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | 24% 102.24K to 126.56K | |
| 21-Jun-24 4:05 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | 50% 48.63K to 72.94K | |
| 21-Jun-24 4:05 PM View: | McHugh Julie Director | Ironwood Pharmaceuticals Inc (IRWD) | 18-Jun-24 | Grant | 24,311 | -- | -- | 17% 139.53K to 163.84K | |
| 18-Jun-24 4:05 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 15-Jun-24 | Grant | 2,572 | -- | -- | < 1% 16.51M to 16.51M | |
| 12-Jun-24 4:05 PM View: | McHugh Julie Director | Ironwood Pharmaceuticals Inc (IRWD) | 10-Jun-24 | Sale (Planned) | 22,766 | $6.29 | $143,198.00 | (14%) 162.29K to 139.53K | |
| 10-Jun-24 4:58 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 07-Jun-24 | Sale | 35,574 | $6.61 | $235,144.00 | (42%) 84.21K to 48.63K | |
| 10-Jun-24 4:58 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 06-Jun-24 | Sale | 44,426 | $6.36 | $282,549.00 | (35%) 128.63K to 84.21K | |
| 22-May-24 4:05 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 20-May-24 | Sale | 22,725 | $6.45 | $146,576.00 | (7%) 310.76K to 288.03K | |
| 22-May-24 4:05 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 20-May-24 | Sale | 17,404 | $6.45 | $112,256.00 | (6%) 311.98K to 294.57K | |
| 22-May-24 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-May-24 | Sale | 67,618 | $6.45 | $436,136.00 | (6%) 1.22M to 1.15M | |
| 22-May-24 4:05 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 20-May-24 | Sale | 16,128 | $6.45 | $104,026.00 | (4%) 429.85K to 413.72K | |
| 20-May-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 16-May-24 | Payment of Exercise | 18,280 | $6.64 | $121,379.00 | (5%) 338.85K to 320.57K | |
| 19-Mar-24 4:05 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 15-Mar-24 | Grant | 1,662 | -- | -- | < 1% 16.51M to 16.51M | |
| 12-Mar-24 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 120,298 | -- | -- | 11% 1.1M to 1.22M | |
| 12-Mar-24 4:05 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 34,936 | -- | -- | 9% 394.91K to 429.85K | |
| 12-Mar-24 4:05 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 37,120 | -- | -- | 14% 273.64K to 310.76K | |
| 12-Mar-24 4:05 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 32,752 | -- | -- | 12% 279.22K to 311.98K | |
| 12-Mar-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 37,120 | -- | -- | 12% 301.73K to 338.85K | |
| 08-Mar-24 4:05 PM View: | Duane Jon R Director | Ironwood Pharmaceuticals Inc (IRWD) | 06-Mar-24 | Private Purchase | 6,920 | $8.70 | $60,204.00 | 6% 114.11K to 121.03K | |
| 07-Mar-24 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 05-Mar-24 | Grant | 264,876 | -- | -- | 32% 832.77K to 1.1M | |
| 06-Mar-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 04-Mar-24 | Private Purchase | 10,684 | $9.38 | $100,216.00 | 4% 291.05K to 301.73K | |
| 14-Feb-24 8:50 PM View: | Silver Ronald Principal Accounting Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 27,213 | -- | -- | 19% 142.17K to 169.38K | |
| 14-Feb-24 9:01 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 47,380 | $15.24 | $722,071.00 | (15%) 326.6K to 279.22K | |
| 14-Feb-24 8:50 PM View: | Silver Ronald Principal Accounting Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 7,908 | $15.24 | $120,518.00 | (5%) 169.38K to 161.48K | |
| 14-Feb-24 9:01 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 54,427 | -- | -- | 20% 272.18K to 326.6K | |
| 14-Feb-24 8:35 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Private Sale | 177,164 | $15.24 | $2,699,980.00 | (18%) 1.01M to 832.77K | |
| 14-Feb-24 8:53 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 38,618 | $15.24 | $588,538.00 | (9%) 433.53K to 394.91K | |
| 14-Feb-24 8:53 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 54,427 | -- | -- | 14% 379.1K to 433.53K | |
| 14-Feb-24 8:42 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 65,312 | -- | -- | 30% 218.17K to 283.48K | |
| 14-Feb-24 8:42 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 9,846 | $15.24 | $150,053.00 | (3%) 283.48K to 273.64K | |
| 14-Feb-24 8:39 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 65,312 | -- | -- | 29% 225.74K to 291.05K | |
| 12-Feb-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Feb-24 | Payment of Exercise | 41,332 | $14.90 | $615,847.00 | (15%) 267.07K to 225.74K | |
| 19-Jan-24 4:05 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 79,981 | -- | -- | 42% 192.19K to 272.18K | |
| 19-Jan-24 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 249,617 | -- | -- | 33% 760.32K to 1.01M | |
| 19-Jan-24 4:05 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 57,971 | -- | -- | 18% 321.13K to 379.1K | |
| 19-Jan-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 85,000 | -- | -- | 47% 182.07K to 267.07K | |
| 19-Dec-23 4:05 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 15-Dec-23 | Grant | 1,572 | -- | -- | 1% 127.06K to 128.63K | |
| 19-Dec-23 4:05 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 15-Dec-23 | Grant | 1,347 | -- | -- | < 1% 16.51M to 16.51M | |
| 18-Dec-23 4:09 PM View: | Kessler Marla L Director | Ironwood Pharmaceuticals Inc (IRWD) | 14-Dec-23 | Market Sale (Planned) | 9,926 | $11.19 | $111,072.00 | (9%) 106.5K to 96.57K | (6%) |
| 22-Nov-23 4:05 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 20-Nov-23 | Sale | 3,287 | $9.69 | $31,851.00 | (1%) 220.66K to 217.37K | |
| 20-Nov-23 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 16-Nov-23 | Payment of Exercise | 6,661 | $9.44 | $62,879.80 | (4%) 188.73K to 182.07K | |
| 19-Sep-23 5:05 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 15-Sep-23 | Grant | 2,098 | -- | -- | 2% 124.96K to 127.06K |
